3690 GENES FOUNDi
Show / hide columns XML | RDF | TSV | « prev | Page of 74 | next »
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x Prognostic p-valuei x RNA tissue categoryi x
ADAM18ADAM metallopeptidase domain 18Predicted membrane proteins
Predicted secreted proteins
Tissue enriched
ADAM22ADAM metallopeptidase domain 22Predicted membrane proteins
Predicted secreted proteins
Cell JunctionsTissue enhanced
ADAM28ADAM metallopeptidase domain 28Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Plasma membrane
Mitochondria
Endometrial cancer: 3.17e-4
Tissue enhanced
ADAM29ADAM metallopeptidase domain 29Disease related genes
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enriched
ADAM32ADAM metallopeptidase domain 32Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Nucleus
Vesicles
Tissue enriched
ADAM33ADAM metallopeptidase domain 33Disease related genes
Predicted membrane proteins
Predicted secreted proteins
Nuclear speckles
Plasma membrane
Mixed
ADAM7ADAM metallopeptidase domain 7Disease related genes
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enriched
ADAM8ADAM metallopeptidase domain 8CD markers
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Renal cancer: 3.99e-10
Tissue enhanced
ADAM9ADAM metallopeptidase domain 9Cancer-related genes
Disease related genes
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Endoplasmic reticulum
Vesicles
Liver cancer: 7.21e-6
Pancreatic cancer: 2.52e-5
Breast cancer: 1.14e-4
Cervical cancer: 2.25e-4
Renal cancer: 3.99e-4
Expressed in all
ADAMDEC1ADAM like decysin 1Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enhanced
ADAMTS1ADAM metallopeptidase with thrombospondin type 1 motif 1Cancer-related genes
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Head and neck cancer: 5.13e-4
Tissue enhanced
ADAMTS10ADAM metallopeptidase with thrombospondin type 1 motif 10Disease related genes
Predicted intracellular proteins
Predicted secreted proteins
CytosolRenal cancer: 4.55e-9
Mixed
ADAMTS12ADAM metallopeptidase with thrombospondin type 1 motif 12Plasma proteins
Predicted secreted proteins
Nucleoli
Mitochondria
Urothelial cancer: 6.78e-4
Mixed
ADAMTS13ADAM metallopeptidase with thrombospondin type 1 motif 13Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted secreted proteins
Mixed
ADAMTS14ADAM metallopeptidase with thrombospondin type 1 motif 14Cancer-related genes
Plasma proteins
Predicted secreted proteins
CytosolTissue enhanced
ADAMTS15ADAM metallopeptidase with thrombospondin type 1 motif 15Predicted secreted proteins
CytosolUrothelial cancer: 5.63e-5
Glioma: 9.00e-4
Lung cancer: 9.72e-4
Tissue enhanced
ADAMTS16ADAM metallopeptidase with thrombospondin type 1 motif 16Predicted secreted proteins
Renal cancer: 3.29e-5
Tissue enhanced
ADAMTS17ADAM metallopeptidase with thrombospondin type 1 motif 17Disease related genes
Predicted intracellular proteins
Predicted secreted proteins
NucleusMixed
ADAMTS18ADAM metallopeptidase with thrombospondin type 1 motif 18Cancer-related genes
Disease related genes
Predicted intracellular proteins
Predicted secreted proteins
Tissue enriched
ADAMTS19ADAM metallopeptidase with thrombospondin type 1 motif 19Predicted secreted proteins
Vesicles
Midbody
Group enriched
ADAMTS2ADAM metallopeptidase with thrombospondin type 1 motif 2Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted secreted proteins
Vesicles
Plasma membrane
Renal cancer: 1.71e-8
Mixed
ADAMTS20ADAM metallopeptidase with thrombospondin type 1 motif 20Cancer-related genes
Predicted intracellular proteins
Predicted secreted proteins
Not detected
ADAMTS3ADAM metallopeptidase with thrombospondin type 1 motif 3Cancer-related genes
Predicted secreted proteins
Intermediate filamentsTissue enhanced
ADAMTS4ADAM metallopeptidase with thrombospondin type 1 motif 4Cancer-related genes
Enzymes
Predicted intracellular proteins
Predicted membrane proteins
Nuclear specklesRenal cancer: 7.27e-7
Lung cancer: 5.00e-4
Tissue enhanced
ADAMTS5ADAM metallopeptidase with thrombospondin type 1 motif 5Cancer-related genes
Predicted secreted proteins
NucleoplasmRenal cancer: 2.46e-4
Thyroid cancer: 8.54e-4
Tissue enhanced
ADAMTS6ADAM metallopeptidase with thrombospondin type 1 motif 6Cancer-related genes
Predicted secreted proteins
Tissue enhanced
ADAMTS7ADAM metallopeptidase with thrombospondin type 1 motif 7Plasma proteins
Predicted secreted proteins
VesiclesStomach cancer: 9.53e-4
Tissue enhanced
ADAMTS8ADAM metallopeptidase with thrombospondin type 1 motif 8Cancer-related genes
Plasma proteins
Predicted secreted proteins
Endometrial cancer: 1.38e-4
Tissue enhanced
ADAMTS9ADAM metallopeptidase with thrombospondin type 1 motif 9Cancer-related genes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Endoplasmic reticulum
Vesicles
Tissue enhanced
ADAMTSL1ADAMTS like 1Predicted intracellular proteins
Predicted secreted proteins
Tissue enhanced
ADAMTSL2ADAMTS like 2Disease related genes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
VesiclesColorectal cancer: 5.01e-4
Pancreatic cancer: 6.70e-4
Tissue enhanced
ADAMTSL3ADAMTS like 3Predicted secreted proteins
VesiclesMixed
ADAMTSL4ADAMTS like 4Disease related genes
Predicted secreted proteins
Plasma membrane
Cytosol
Renal cancer: 4.35e-7
Glioma: 1.63e-4
Colorectal cancer: 1.86e-4
Tissue enhanced
ADAMTSL5ADAMTS like 5Predicted intracellular proteins
Predicted secreted proteins
Golgi apparatusTissue enhanced
ADARB2Adenosine deaminase, RNA specific B2 (inactive)Predicted intracellular proteins
Tissue enriched
ADAT1Adenosine deaminase, tRNA specific 1Enzymes
Predicted intracellular proteins
NucleoplasmExpressed in all
ADCK1AarF domain containing kinase 1Enzymes
Predicted secreted proteins
NucleoplasmRenal cancer: 5.82e-6
Lung cancer: 4.11e-5
Liver cancer: 1.70e-4
Mixed
ADCY4Adenylate cyclase 4Enzymes
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Renal cancer: 7.01e-4
Endometrial cancer: 8.20e-4
Tissue enhanced
ADCY7Adenylate cyclase 7Enzymes
Predicted intracellular proteins
Predicted membrane proteins
CytosolCervical cancer: 5.31e-4
Mixed
ADCYAP1Adenylate cyclase activating polypeptide 1Predicted secreted proteins
Renal cancer: 2.91e-6
Tissue enhanced
ADCYAP1R1ADCYAP receptor type IG-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Transporters
VesiclesEndometrial cancer: 5.78e-4
Tissue enhanced
ADGRA3Adhesion G protein-coupled receptor A3G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
ADGRB2Adhesion G protein-coupled receptor B2G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
CentrosomeLung cancer: 4.02e-5
Breast cancer: 6.46e-4
Tissue enriched
ADGRD1Adhesion G protein-coupled receptor D1G-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Nucleus
Cytosol
Liver cancer: 9.27e-4
Tissue enhanced
ADGRE3Adhesion G protein-coupled receptor E3G-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
ADGRE5Adhesion G protein-coupled receptor E5CD markers
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
CytosolRenal cancer: 1.87e-6
Liver cancer: 3.73e-5
Expressed in all
ADGRF1Adhesion G protein-coupled receptor F1G-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Renal cancer: 1.35e-5
Tissue enhanced
ADGRG1Adhesion G protein-coupled receptor G1Disease related genes
G-protein coupled receptors
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Renal cancer: 5.52e-7
Head and neck cancer: 2.53e-4
Expressed in all
ADGRG5Adhesion G protein-coupled receptor G5G-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Nucleoplasm
Nuclear membrane
Vesicles
Cervical cancer: 4.25e-4
Tissue enhanced
ADGRG6Adhesion G protein-coupled receptor G6Disease related genes
G-protein coupled receptors
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Pancreatic cancer: 2.78e-5
Lung cancer: 8.78e-4
Tissue enhanced
« prev | Page of 74 | next »